|
LTC3057969I2
(en)
|
|
COMPOSITIONS USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH KIT
|
|
DK3334422T3
(en)
|
|
USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF EPILEPSY
|
|
GB201614522D0
(en)
|
|
Use of cannabinoids in the treatment of multiple myeloma
|
|
DK3490582T3
(en)
|
|
COMPOSITIONS FOR USE IN THE TREATMENT OF MYELOFIBROSIS
|
|
BR112017011771A2
(en)
|
|
methods and compositions for cancer treatment
|
|
DK3778595T3
(en)
|
|
Pancreatitis treatment
|
|
DK3481846T3
(en)
|
|
11-SUBSTITUTED 24-HYDROXYSTEROLS FOR USE IN THE TREATMENT OF NMDA-RELATED CONDITIONS
|
|
DK3015526T3
(en)
|
|
HYDROFLUOROLEFIN-BASED COMPOSITION AND USE
|
|
DK3185957T3
(en)
|
|
Patisiran for use in the treatment of transthyretin-mediated amyloidosis
|
|
DK3882250T3
(en)
|
|
TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE FOR USE IN THE TREATMENT OF BTK-MEDIATED DISORDERS
|
|
DK3102200T3
(en)
|
|
Therapeutic compound and composition
|
|
DK3231444T3
(en)
|
|
New treatment
|
|
BR112016022976A2
(en)
|
|
METHODS FOR THE TREATMENT OF HCV
|
|
DK3391902T3
(en)
|
|
PLASMINOGEN FOR USE IN THE TREATMENT OF DIABETIC ANGIOCARDIOPATHY
|
|
DK3374497T3
(en)
|
|
MODIFIED MACROPHAGE FOR USE IN THE TREATMENT OF CANCER
|
|
DK3302519T3
(en)
|
|
ORNITHODOROS-MOUBATA-COMPLEMENT-INHIBITOR FOR USE IN THE TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
|
|
DK3373874T3
(en)
|
|
Medical dressing
|
|
DK3164123T3
(en)
|
|
Novel uses of benzylideneguanidine derivatives in the treatment of proteopathies
|
|
DK3442558T3
(en)
|
|
BMP-7-DERIVED PEPTIMES FOR USE IN THE TREATMENT OF OSTEOARTHRITIS
|
|
DK3302478T3
(en)
|
|
PAC-1 COMBINATION TREATMENT
|
|
DK3283064T3
(en)
|
|
Derivatives for use in the treatment of muscle atrophy
|
|
HK1225994A1
(en)
|
|
Compositions for use in the treatment of allergic conditions
|
|
DK3373922T3
(en)
|
|
COMPOSITIONS AND PROCEDURES FOR USE IN THE TREATMENT OF HOMOCYSTINURI
|
|
KR20180084983A
(en)
|
|
Uses of Pyrimido-Pyrimidazinone for the Treatment of Cancer
|
|
DK3233104T3
(en)
|
|
IMMUNTERY TREATMENTS AND COMPOSITIONS
|